↓ Skip to main content

Extended adjuvant endocrine treatment for premenopausal women: A Delphi approach to guide clinical practice

Overview of attention for article published in Frontiers in oncology, October 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

twitter
12 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Extended adjuvant endocrine treatment for premenopausal women: A Delphi approach to guide clinical practice
Published in
Frontiers in oncology, October 2022
DOI 10.3389/fonc.2022.1032166
Pubmed ID
Authors

Giuseppe Buono, Grazia Arpino, Lucia Del Mastro, Alessandra Fabi, Daniele Generali, Fabio Puglisi, Alberto Zambelli, Saverio Cinieri, Francesco Nuzzo, Vincenzo Di Lauro, Paolo Vigneri, Giampaolo Bianchini, Filippo Montemurro, Alessandra Gennari, Michelino De Laurentiis

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Other 1 17%
Unknown 5 83%
Readers by discipline Count As %
Medicine and Dentistry 1 17%
Unknown 5 83%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 October 2022.
All research outputs
#5,402,348
of 26,246,850 outputs
Outputs from Frontiers in oncology
#1,871
of 22,949 outputs
Outputs of similar age
#106,055
of 446,557 outputs
Outputs of similar age from Frontiers in oncology
#113
of 1,761 outputs
Altmetric has tracked 26,246,850 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,949 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,557 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 1,761 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.